Cost analysis review of a patient navigator and fecal immunochemical testing on colorectal cancer screening in an underserved population

Author:

Fiske Hannah W.ORCID,Monteiro Joao Filipe G.,Hilliard Ross W.,Grisson Ricky,Holloway Marlaydis,Feliz Carrie Bridges,Rich Harlan

Abstract

Abstract Background Colorectal cancer screening is a critical preventative service and part of routine patient care, yet a substantial portion of the population fails to undergo recommended screening. Aims To investigate the impact and cost-effectiveness of a patient navigator on colorectal cancer screening via fecal immunochemical testing. Methods Design: retrospective analysis investigating structured outreach via a dedicated patient navigator. Location: Center for Primary Care, Rhode Island Hospital’s primary safety-net clinic for adult patients in Providence, Rhode Island. Timing: the study ran between 01/2017 and 12/2021, with the intervention introduced 01/2021. Results This study included 3542 patients. The intervention improved completion rates from 64.7 to 74.5% at 1 month (HR 1.12, 95%CI [1.003–1.243]), 73.7% to 90.1% at 3 months (1.28[1.156–1.410]), and 87.8 to 98.8% at 1 year (1.36 [1.239–1.498]). Overall, completion rates were improved by 38.5% (1.39[1.260–1.522]). Total cost of colorectal cancer screening per patient was decreased by $874.18 in the post-intervention group ($72.0 ± 383.3 vs. $946.1 ± 1873.5, p < 0.0001). Conclusions In this retrospective analysis, our targeted intervention improved fecal immunochemical testing kit return rates and significantly reduced screening costs. The addition of a dedicated patient navigator is critical to ensuring compliance with screening guidelines, particularly for deprived and/or medically underserved populations. Health care systems, insurance companies and payers, and state health departments should actively and consistently support this role, as it will allow fecal immunochemical testing to reach and risk-stratify more patients, increasing the yield of colonoscopy for detecting advanced neoplasia and cancer and subsequently reducing pressure on endoscopy centers.

Publisher

Springer Science and Business Media LLC

Reference34 articles.

1. An update on cancer deaths in the United States. Centers for disease control and prevention. Published February 28, 2022. https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm#:~:text=51%2C869%20people%20died%20of%20colorectal

2. Final Recommendation Statement: Colorectal cancer: screening. U.S. Preventive services task force. Published May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening

3. Cancer Data. Department of health. https://health.ri.gov/data/cancer

4. Perisetti A, Goyal H, Sharma N. Gastrointestinal endoscopy in the era of COVID-19. Front Med. 2020. https://doi.org/10.3389/fmed.2020.587602.

5. Preventive Cancer Screenings during COVID-19 Pandemic. Epic Health Research Network. Published May 1, 2020. https://ehrnprd.blob.core.windows.net/wordpress/pdfs/Preventive-Cancer-Screenings-during-COVID-19-Pandemic.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3